Sandy, Utah (August 28, 2006) 4Life Research™ announced today the successful Philippines launch of 4Life Transfer Factor® Belle Vie™ and 4Life Transfer Factor énummi™, two of its newest products. The event was held on August 19 at the Edsa Shangri-la Hotel in Mandaluyong City, Manila, Philippines, and was attended by 450 people. Steve Apple, Vice President of International, and Glenn Ortega, General Manager of 4Life Philippines, were on hand to personally launch the new products.
The theme of the evening was “A Beautiful Life”, and emphasized the powerful health protection provided by the new products, allowing people to enjoy family, success, wealth, and other components of a rewarding life.
Belle Vie was introduced with a video presentation that celebrated the various roles of women, and incorporated two real-life stories about women of courage. To highlight énummi, a live sketch communicated how the product provides topical immune protection for healthy, glowing skin.
International Diamonds, Presidential Diamonds, and Qualified Diamonds were recognized on stage, including International Diamonds Maria Din from Singapore and Mohd Dzamri Abdullah from Malaysia. Platinum International Diamond Jeff Altgilbers was invited to speak to the audience.
“It was a truly beautiful evening,” commented Steve Apple. “I’m so thankful I could attend the event, help introduce these new products, and personally shake hands with so many dedicated and passionate Filipino distributors.”
Glenn Ortega remarked, “From beginning to end, this event was amazing. We’re thrilled to have two new 4Life Transfer Factor products in the Philippines, and look forward to the added health support they will provide. I’m so proud to be associated with such wonderful distributors, and I’m continually impressed with their commitment to 4Life® and Together, Building People.”
4Life, the leader in the development, production, and distribution of Transfer Factor immune support products, continues to post growth in more than 40 countries around the world.
No comments:
Post a Comment